Disease/Infection News

RSS

Regular exercise key to unlocking whole-body health benefits and reducing disease risk

Study in Cell Metabolism explores how chronic exercise induces tissue adaptations, enhancing cardiometabolic health and reducing disease risk.

8 Jan 2024

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Recent study reveals nirmatrelvir treatment during acute COVID-19 does not lower the risk of post-acute COVID-19 symptoms, nor is it associated with symptomatic rebound.

8 Jan 2024

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

Measuring airborne grass allergen levels instead of pollen counts will be more beneficial for hay fever sufferers as new research shows grass allergen levels are more consistently associated with hay fever symptoms than grass pollen counts.

8 Jan 2024

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

8 Jan 2024

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

A study led by UTHealth Houston reveals that T-cells specific for Epstein-Barr virus-infected cells are highly present in the cerebrospinal fluid of people with early-stage multiple sclerosis, suggesting a link between EBV and the disease.

8 Jan 2024

Long COVID's hidden toll: How does post-exertional malaise affect skeletal muscles?

Study investigates the pathophysiology of post-exertional malaise in long COVID patients, revealing skeletal muscle changes, exercise capacity reduction, metabolic disturbances, and tissue alterations.

8 Jan 2024

Three cytokine pairs found to be responsible for the body's damaging response to sepsis

Sepsis - when an infection causes the immune system to improperly target the body - is one of the leading causes of death in the ICU.

8 Jan 2024

Rising out-of-pocket costs for PrEP threaten key strategy in ending the HIV epidemic

Increasing patients' out of pocket costs for HIV pre-exposure prophylaxis (PrEP), medications, which have been shown to dramatically reduce the risk of HIV infection, could lead to a significant reduction in PrEP use and a rise in HIV infection rates, according to a new study co-led by researchers at the Perelman School of Medicine at the University of Pennsylvania and Johns Hopkins Bloomberg School of Public Health.

8 Jan 2024

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

It's winter, that cozy season that brings crackling fireplaces, indoor gatherings — and a wave of respiratory illness.

8 Jan 2024

Does SARS-CoV-2's ability to infect humans stem from its evolutionary past?

Study challenges the hypothesis of genetic recombination in SARS-CoV-2's evolution, suggesting its ancestral virus already possessed human-infecting traits, based on analyses of over 100 viral genomes.

7 Jan 2024

Genetic keys to COVID-19 vaccine response unlocked

A genome-wide association study in the U.K. Biobank reveals genetic factors influencing IgG serostatus against SARS-CoV-2, highlighting the role of HLA class II genes in variable immune responses to COVID-19 vaccines.

7 Jan 2024

Inpatient costs of treating COVID-19 in the U.S.

Study analyzes the average inpatient care costs for COVID-19 patients, revealing significant variations in expenses across pandemic waves and patient demographics.

7 Jan 2024

Sesame protein-derived peptides show promise in fighting E. coli and S. aureus

A study in "Nutrients" reveals that sesame protein-derived peptides, Ala-Gly-Gly-Val-Pro-Arg and Ser-Thr-Ile-Arg, show effective antibacterial activity against Escherichia coli and Staphylococcus aureus.

7 Jan 2024

University of Louisville scientists aim to disarm Yersinia pestis, the bubonic plague bacteria

When the body encounters bacteria, viruses or harmful substances, its innate immune cells, neutrophils, assemble at the site to combat the invader.

5 Jan 2024

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

Scientists at St. Jude Children's Research Hospital are tackling Mycobacterium abscessus (Mab) antibiotic resistance.

5 Jan 2024

Stapled lipopeptides show promise as broad-spectrum antiviral agents

Compounds that obstruct the "landing gear" of a range of harmful viruses can successfully protect against infection by the virus that causes COVID-19, a study published today and led by Dana-Farber Cancer Institute scientists shows.

5 Jan 2024

UKHSA urges eligible groups to get vaccinated against flu and COVID-19

The UK Health Security Agency (UKHSA) is reminding all those eligible that it's not too late to book their flu and COVID-19 vaccinations.

5 Jan 2024

COVID-19's unseen impact: study reveals surge in home deaths across 32 countries

Trends in places of death across 32 countries during and before the COVID-19.

5 Jan 2024

40-year timeline of HIV: Testing assays, global burden, prevalence, treatment, and challenges

Announcing a new article publication for Zoonoses journal. More than 77 million individuals have been infected with the human immunodeficiency virus (HIV) and approximately 37.6 million people are living with HIV infection.

4 Jan 2024

Early pandemic sees drop in child UTI diagnoses, severity unchanged

A cohort study in JAMA Network Open found a decrease in urinary tract infection (UTI) diagnoses among children during the early COVID-19 pandemic without an increase in disease severity, suggesting a potential reduction in over- or misdiagnosis.

4 Jan 2024

Disease/Infection News

Regular exercise key to unlocking whole-body health benefits and reducing disease risk

Nirmatrelvir treatment shows no link to reduced long-COVID risk, study reveals

Measuring airborne grass allergen levels could be key to controlling hay fever symptoms

SARS-CoV-2 BA.2.86 shows increased lung targeting despite vaccine effectiveness

Study finds Epstein-Barr virus T-cells prevalent in early multiple sclerosis

Long COVID's hidden toll: How does post-exertional malaise affect skeletal muscles?

Three cytokine pairs found to be responsible for the body's damaging response to sepsis

Rising out-of-pocket costs for PrEP threaten key strategy in ending the HIV epidemic

There’s a new covid-19 variant and cases are ticking up. What do you need to know?

Does SARS-CoV-2's ability to infect humans stem from its evolutionary past?

Genetic keys to COVID-19 vaccine response unlocked

Inpatient costs of treating COVID-19 in the U.S.

Sesame protein-derived peptides show promise in fighting E. coli and S. aureus

University of Louisville scientists aim to disarm Yersinia pestis, the bubonic plague bacteria

St. Jude scientists develop novel spectinomycin derivatives to combat Mycobacterium abscessus

Stapled lipopeptides show promise as broad-spectrum antiviral agents

UKHSA urges eligible groups to get vaccinated against flu and COVID-19

COVID-19's unseen impact: study reveals surge in home deaths across 32 countries

40-year timeline of HIV: Testing assays, global burden, prevalence, treatment, and challenges

Early pandemic sees drop in child UTI diagnoses, severity unchanged

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News